No results, please enter a search term above
|Date of Alert|
|No Health Alerts Found|
|Tickborne Diseases in Philadelphia: Recognition, Reporting, and Prevention||Advisory||Jun 24, 2022|
|Tickborne Diseases: Recognition, Reporting, and Prevention||Advisory||Jun 9, 2021|
|Tickborne Diseases in Philadelphia: Recognition, Reporting, and Prevention||Advisory||Jul 2, 2020|
|Tickborne Diseases in Philadelphia: Recognition, Reporting, and Prevention||Advisory||May 22, 2019|
|Tickborne Diseases in Philadelphia: Recognition, Reporting, and Prevention||Advisory||May 31, 2018|
No vaccines are currently available for tickborne disease. Click here to learn about research to develop a Lyme disease vaccine.
Prevention of tick bites is the only way to keep patients from contracting a tickborne illness. Advise patients to:
Patients with tickborne infectious often present with non-specific symptoms including fever, fatigue, and myalgia/arthralgia sometimes making diagnosis challenging.
Health care providers can use the Summer Fever Algorithm here to aid in the diagnosis and differentiation of tickborne diseases.
Testing for Lyme Disease:
Disseminated Disease and Complications:
Individuals who do not receive prompt treatment often experience disseminated symptoms as the Borrelia burdorferi spreads from the initial site of infection. Important complications of B. burgdorferi infection include arthritis, Bell’s palsy/cranial neuritis, Lyme meningitis and Lyme carditis, which has been identified as a contributing factor in at least three sudden cardiac deaths. While Lyme disease does not frequently result in death, it is important to consider as a contributing factor.
Post-Treatment Lyme Disease Syndrome:
Even after treatment with antibiotics, a small percentage of patients may still experience fatigue, arthralgia, and/or myalgia. Commonly described as “chronic Lyme disease,” this condition is termed Post-treatment Lyme Disease Syndrome (PTLDS). The cause of PTLDS is not well understood, but most medical experts attribute the symptoms to the residual damage of the tissues and immune system initiated prior to treatment. Research into the underlying cause and best methods for treating PTLDS is ongoing. Further information and resources can be found here on the CDC’s webpage.
Report any suspected or confirmed cases of anaplasmosis, babesiosis, ehrlichiosis, Lyme disease (including erythema migrans without confirmatory lab testing), or Rickettsial diseases to PDPH by calling 215-685-6748 during business hours or by faxing a disease report form to 215-238-6947.
The Philadelphia Department of Public Health relies on the efforts of health care providers and other public health partners to protect the health and wellness of Philadelphia residents by reporting tickborne diseases. As part of routine disease surveillance, PDPH receives reports from healthcare providers and commercial laboratories when a Philadelphia resident tests positive for a tickborne pathogen. After collecting laboratory, symptom, and exposure information from the treating physician, the case is classified using criteria determined by the Council of State and Territorial Epidemiologists (CSTE). Individuals who meet the case criteria are interviewed to obtain more detailed exposure information
Clinical Guidelines for Healthcare Providers
Provider Education on Tickborne Diseases
Research for Tickborne Diseases
There are no patient or community resources for Tickborne Diseases (Lyme, Babesiosis, Rickettsial).
There are no posters for Tickborne Diseases (Lyme, Babesiosis, Rickettsial).